Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib versus nilotinib in children with chronic myeloid leukemia
jRCTs041190038Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in chronic myelogenous leukemia (CML) comparing Dasatinib group with Nilotinib group (2 arms). Started Jun 2019; status: active, not recruiting.
02
Drugs
dasatinibnilotinib
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on jRCTs041190038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190038.